MLC.IR

Malin Corporation plc [MLC.IR] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MLC.IR Stock Summary

Top 10 Correlated ETFs

MLC.IR

Top 10 Correlated Stocks

MLC.IR

In the News

MLC.IR Financial details

Company Rating
-
Market Cap
111.45M
Income
12.8K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
14 Feb 2024
P/E
12.12
Forward P/E
-
PEG
-0.03
P/S
-
P/B
0.55
P/C
-
P/FCF
-12.01
Quick Ratio
289.83
Current Ratio
291.83
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.38
EPS next Y
-
EPS next Q
-
EPS this Y
-3492.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-10%
SMA50
-10%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
4%
ROE
5%
ROC
0.05%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.84-6.1
52W High
+41.67%
52W Low
+183.33%
RSI
35
Rel Volume
0.06
Avg Volume
13.64K
Volume
776
Perf Week
-6.59%
Perf Month
-17.48%
Perf Quarter
46.55%
Perf Half Y
44.07%
-
-
-
-
Beta
0.986
-
-
Volatility
0%, 0.68%
Prev Close
0%
Price
8.5
Change
1.19%

Something similar

Top by Market Cap
M&M.NS
META
BRK-B
FXAIX
3V64.DE
Top Correlated ETFs
FCUH.TO
FCMI.TO
CGRE.TO
BRT3.L
UC95.L
Top Correlated Stocks
0474.HK
0057.HK
0156.HK
0646.HK
8241.HK
Similar Market Cap
DISA
1701.HK
0261.HK
PRAG.DE
RUDH.TO

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 13.64K
  • Market Capitalization 111.45M
  • Employee 3
  • CEO Mr. William F. Daniel
  • Headquarters Dublin,IE
  • IPO Date 2014-03-25
  • Website https://malinplc.com

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.